Cargando…

TRAF3IP2, a novel therapeutic target in glioblastoma multiforme

Glioblastoma multiforme (glioblastoma) remains one of the deadliest cancers. Pro-inflammatory and pro-tumorigenic mediators present in tumor microenvironment (TME) facilitate communication between tumor cells and adjacent non-malignant cells, resulting in glioblastoma growth. Since a majority of the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Alt, Eckhard U., Barabadi, Zahra, Pfnür, Andreas, Ochoa, Joana E., Daneshimehr, Fatemeh, Lang, Lea M., Lin, Dong, Braun, Stephen E., Chandrasekar, Bysani, Izadpanah, Reza
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2018
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6049871/ https://www.ncbi.nlm.nih.gov/pubmed/30038719 http://dx.doi.org/10.18632/oncotarget.25710

Ejemplares similares

Targeting TRAF3IP2 inhibits angiogenesis in glioblastoma
por: Izadpanah, Amin, et al.
Publicado: (2022)

Targeting TRAF3IP2, Compared to Rab27, is More Effective in Suppressing the Development and Metastasis of Breast Cancer
por: Alt, Eckhard U., et al.
Publicado: (2020)

Angiogenesis and Its Targeting in Glioblastoma with Focus on Clinical Approaches
por: Daneshimehr, Fatemeh, et al.
Publicado: (2022)

Understanding cytoskeleton regulators in glioblastoma multiforme for therapy design
por: Masoumi, Samaneh, et al.
Publicado: (2016)

Dipeptidyl peptidase-4 (DPP-4) inhibition with linagliptin reduces western diet-induced myocardial TRAF3IP2 expression, inflammation and fibrosis in female mice
por: Aroor, Annayya R., et al.
Publicado: (2017)

NPR3 protects cardiomyocytes from apoptosis through inhibition of cytosolic BRCA1 and TNF-α
por: Lin, Dong, et al.
Publicado: (2016)

Glioblastoma Multiforme
por: Sheehan, Jonas M., et al.
Publicado: (2012)

Glioblastoma multiforme – an overview
por: Urbańska, Kaja, et al.
Publicado: (2014)

Incidentalomas to glioblastoma multiforme
por: Sachdev, Bobby, et al.
Publicado: (2014)

Diagnostic and prognostic value of stem cell factor plasma level in glioblastoma multiforme patients
por: Kefayat, Amirhosein, et al.
Publicado: (2021)

lobChIP: from cells to sequencing ready ChIP libraries in a single day
por: Wallerman, Ola, et al.
Publicado: (2015)

Network Signatures of Survival in Glioblastoma Multiforme
por: Patel, Vishal N., et al.
Publicado: (2013)

Tectal plate glioblastoma multiforme
por: Nemer, Michael D., et al.
Publicado: (2011)

Bilateral cystic glioblastoma multiforme
por: Kumar, Sushil, et al.
Publicado: (2013)

Glioblastoma Multiforme Stem Cells
por: Dimov, Irena, et al.
Publicado: (2011)

Atypical Presentation of Glioblastoma Multiforme
por: Al-Janabi, Wissam, et al.
Publicado: (2018)

Nanotechnology for Treatment of Glioblastoma Multiforme
por: Michael, Justin S., et al.
Publicado: (2018)

The complement system in glioblastoma multiforme
por: Bouwens van der Vlis, T. A. M., et al.
Publicado: (2018)

Temozolomide resistance in glioblastoma multiforme
por: Lee, Sang Y.
Publicado: (2016)

Survival Analysis of Glioblastoma Multiforme
por: Witthayanuwat, Supapan, et al.
Publicado: (2018)

Advances in Immunotherapy for Glioblastoma Multiforme
por: Huang, Boyuan, et al.
Publicado: (2017)

Targeted Nanotechnology in Glioblastoma Multiforme
por: Glaser, Talita, et al.
Publicado: (2017)

Prion Protein in Glioblastoma Multiforme
por: Ryskalin, Larisa, et al.
Publicado: (2019)

Current Immunotherapies for Glioblastoma Multiforme
por: Huang, Boyuan, et al.
Publicado: (2021)

Glioblastoma Multiforme Masquerading as Stroke
por: Remley, William, et al.
Publicado: (2021)

Advances in immunotherapy for glioblastoma multiforme
por: Mahmoud, Ahmad Bakur, et al.
Publicado: (2022)

The SOX2 response program in glioblastoma multiforme: an integrated ChIP-seq, expression microarray, and microRNA analysis
por: Fang, Xuefeng, et al.
Publicado: (2011)

Simultaneous impact of atorvastatin and mesenchymal stem cells for glioblastoma multiform suppression in rat glioblastoma multiform model
por: Goodarzi, Arash, et al.
Publicado: (2020)

Prognostic Significance of TNFR-Associated Factor 1 and 2 (TRAF1 and TRAF2) in Glioblastoma
por: Zhang, Wenqing, et al.
Publicado: (2017)

TSPAN4 is a prognostic and immune target in Glioblastoma multiforme
por: Zheng, Yue, et al.
Publicado: (2023)

PARP-1 protein expression in glioblastoma multiforme
por: Galia, A., et al.
Publicado: (2012)

Identification of human mutations in TRAF3IP1 in patients with nephronophthisis and retinal degeneration
por: Becker-Heck, A, et al.
Publicado: (2015)

Canadian recommendations for the treatment of glioblastoma multiforme
por: Mason, W.P., et al.
Publicado: (2007)

Targeting Metabolic Remodeling in Glioblastoma Multiforme
por: Wolf, Amparo, et al.
Publicado: (2010)

Glioblastoma Multiforme Oncogenomics and Signaling Pathways
por: Kanu, Okezie O., et al.
Publicado: (2009)

Glioblastoma Multiforme: Novel Therapeutic Approaches
por: Fialho, Arsenio M., et al.
Publicado: (2012)

Pediatric Cerebellar Hemorrhagic Glioblastoma Multiforme
por: Kalina, Peter
Publicado: (2012)

Morphometic analysis of TCGA glioblastoma multiforme
por: Chang, Hang, et al.
Publicado: (2011)

Supratentorial glioblastoma multiforme with spinal metastases
por: Shah, Abhidha, et al.
Publicado: (2010)

Current data and strategy in glioblastoma multiforme
por: Iacob, G, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_a4k9ehhd9k76lhphei1c7sidv3